跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,802 条关于
“EBV antigens”
全部
4,802
临床试验
2,794
药物
1,143
机构
106
资讯
759
2年前
Biosyngen's BRG01 CAR-T Therapy Enters Phase II Trial for Nasopharyngeal Carcinoma After Promising Phase I Results
去年
Australian Clinical Trials Test Antiviral Drugs Targeting Epstein-Barr Virus for Multiple Sclerosis Treatment
3个月前
VT-EBV-N Shows 95% Durable Disease-Free Survival in EBV-Positive ENKTL: Phase II Data at EHA 2026
3个月前
Latent EBV Infection Enhances Anti-CD3 Antibody Efficacy in Type 1 Diabetes
去年
Tabelecleucel Shows Sustained Efficacy in EBV+ PTLD, FDA Decision Expected in January 2025
去年
Tivumecirnon-Keytruda Combination Shows Promise in EBV-Positive Gastric Cancer Trial
去年
FDA-Approved PARP Inhibitor Shows 80% Tumor Reduction in EBV-Driven Lymphoma
去年
Cell Therapy Shows Promise for EBV-Driven Post-Transplant Lymphoproliferative Disease
去年
ModeX Therapeutics' Epstein-Barr Virus Vaccine Enters Phase I Trial in Collaboration with Merck
去年
mRNA Vaccine Trial Aims to Prevent Epstein-Barr Virus and Associated Diseases
第 1 页,共 76 页
上一页
下一页